methylcyclopentadiene has been researched along with Colorectal Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Avecilla, F; Brás, AR; Côrte-Real, L; Garcia, MH; Haukka, M; Moreira, T; Preto, A; Robalo, MP; Sanches, A; Tatikonda, R; Teixeira, RG; Valente, A | 1 |
1 other study(ies) available for methylcyclopentadiene and Colorectal Neoplasms
Article | Year |
---|---|
Novel ruthenium methylcyclopentadienyl complex bearing a bipyridine perfluorinated ligand shows strong activity towards colorectal cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Cycloparaffins; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Ligands; Molecular Structure; Organometallic Compounds; Pyridines; Ruthenium; Structure-Activity Relationship | 2018 |